-
Insulin Use During Gestational and Pre-existing Diabetes in Pregnancy: A Systematic Review of Study Design Diabetes Ther. (IF 3.8) Pub Date : 2024-03-18 Kristin Castorino, Beatrice Osumili, Theophilus Lakiang, Kushal Kumar Banerjee, Andrea Goldyn, Carolina Piras de Oliveira
-
Evaluating the Safety and Efficacy of Sodium-Glucose Co-transporter 2 Inhibitors in Subjects with Prediabetes: A Protocol for a Randomized Controlled Trial Diabetes Ther. (IF 3.8) Pub Date : 2024-03-18 Xiaxuan Zhu, Li Xia, Deshan Yin, Jin Yang, Rui Wei
-
Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes: Analysis of SURPASS-AP-Combo by Different Subgroups Diabetes Ther. (IF 3.8) Pub Date : 2024-03-18 Yan Bi, Song Lu, Jiani Tang, Liying Du, Linong Ji
-
Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study Diabetes Ther. (IF 3.8) Pub Date : 2024-03-18 Sakiko Terui, Mari Igari, Takahiro Tsuno, Tomoko Okuyama, Ryota Inoue, Mayu Kyohara, Yasuo Terauchi, Jun Shirakawa
-
The Implication of Diabetes-Specialized Nurses in Aiming for the Better Treatment and Management of Patients with Diabetes Mellitus: A Brief Narrative Review Diabetes Ther. (IF 3.8) Pub Date : 2024-03-12
Abstract Diabetes mellitus (DM) is regarded as one of the most critical public health challenges of the 21st century. It has evolved into a burgeoning epidemic since the last century, and today ranks among the major causes of mortality worldwide. Diabetes specialist nurses (DSNs) are central to good patient care and outcomes including confident self-care management. Evidence shows that DSNs are cost-effective
-
Expert Opinion on Current Trends in the Use of Insulin in the Management of People with Type 2 Diabetes from the South-Eastern European Region and Israel Diabetes Ther. (IF 3.8) Pub Date : 2024-03-12 Adam G. Tabak, Peter Kempler, Cristian Guja, Roy Eldor, Martin Haluzik, Tomasz Klupa, Nikolaos Papanas, Anca Pantea Stoian, Boris Mankovsky
Despite the availability of various antihyperglycaemic therapies and comprehensive guidelines, glycaemic control in diabetes management has not improved significantly during the last decade in the real-world clinical setting. Treatment inertia arising from a complex interplay among patient-, clinician- and healthcare-system-related factors is the prime reason for this suboptimal glycaemic control.
-
Insulin Degludec in People with Type 2 Diabetes in China: A Non-interventional, Retrospective Chart Review Study (CN-TREAT) Diabetes Ther. (IF 3.8) Pub Date : 2024-03-05 Weimin Wang, Xiangyun Chang, Lars Lang Lehrskov, Ling Li, Mads Nordentoft, Jinxing Quan, Yubo Sha, Xing Zhong, Caixian Yang, Dalong Zhu
-
Real-World Use of Oral and Subcutaneous Semaglutide in Routine Clinical Practice in the UK: A Single-Centre, Retrospective Observational Study Diabetes Ther. (IF 3.8) Pub Date : 2024-03-01 Sharmistha Roy Chowdhury, Fethi Sadouki, Edward Collins, Frederick Keen, Ridhi Bhagi, Yuan S. J. Lim, Silviu L. Cozma, Stephen C. Bain
-
Glycemic and Cost Outcomes among Hispanic/Latino People with Type 2 Diabetes in the USA Initiating Dulaglutide versus Basal Insulin: a Real-World Study Diabetes Ther. (IF 3.8) Pub Date : 2024-03-01 Meredith Hoog, Juan M. Maldonado, Ruth Wangia-Dixon, Rachel Halpern, Erin Buysman, Garrett W. Gremel, Ahong Huang, Manige Konig
-
Impact of Glucagon-Like Peptide 1 Agonist Deprescription in Type 2 Diabetes in a Real-World Setting: A Propensity Score Matched Cohort Study Diabetes Ther. (IF 3.8) Pub Date : 2024-02-29
Abstract Introduction Glucagon-like peptide 1 receptor agonists (GLP-1) elicit substantial reductions in glycemia and body weight in people with type 2 diabetes (T2D) and obesity, but existing data suggest the therapy must be continued indefinitely to maintain clinical improvements. Given the high cost and poor real-world persistence of GLP-1, an effective therapy that enables deprescription with sustained
-
Cardiovascular Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetes: A Real-World Data Analysis Diabetes Ther. (IF 3.8) Pub Date : 2024-02-24 Jonathan Y. M. Lai, David R. Riley, Matthew Anson, Alex Henney, Daniel J. Cuthbertson, Gema Hernadez, Philip Austin, Gregory Y. H. Lip, Sizheng Steven Zhao, Timothy L. Jackson, Katarzyna Nabrdalik, Uazman Alam
-
Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study Diabetes Ther. (IF 3.8) Pub Date : 2024-02-24 Kazuo Hara, Tetsuaki Hirase, Swathi Pathadka, Zhihong Cai, Manaka Sato, Noriyuki Ishida, Ryo Takemura
-
Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist Diabetes Ther. (IF 3.8) Pub Date : 2024-02-24 Xiaosu Ma, Rong Liu, Edward J. Pratt, Charles T. Benson, Shobha N. Bhattachar, Kyle W. Sloop
-
Comparative Efficacy and Safety of Tirzepatide in Asians and Non-Asians with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis Diabetes Ther. (IF 3.8) Pub Date : 2024-02-24 Yuying Cui, Jinming Yao, Xiaodong Qiu, Congcong Guo, Degang Kong, Jianjun Dong, Lin Liao
-
Personalized Versus Non-personalized Nutritional Recommendations/Interventions for Type 2 Diabetes Mellitus Remission: A Narrative Review Diabetes Ther. (IF 3.8) Pub Date : 2024-02-20 Ana T. Arias-Marroquín, Fabiola M. Del Razo-Olvera, Zaira M. Castañeda-Bernal, Eustorgio Cruz-Juárez, María F. Camacho-Ramírez, Daniel Elías-López, Miguel A. Lara-Sánchez, Lucía Chalita-Ramos, Valeria Rebollar-Fernández, Carlos A. Aguilar-Salinas
-
Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan Diabetes Ther. (IF 3.8) Pub Date : 2024-02-16 Daisuke Yabe, Munehide Matsuhisa, Yoko Takahashi, Yukiko Morimoto, Yasuo Terauchi
-
Menopausal Hormone Therapy in Women with Type 2 Diabetes Mellitus: An Updated Review Diabetes Ther. (IF 3.8) Pub Date : 2024-02-16
Abstract Menopause is accompanied by several metabolic adaptations, which are related to insulin resistance, increased total body fat mass, and central abdominal fat accumulation, predisposing women to type 2 diabetes mellitus (T2DM) development. Metabolic syndrome has a high prevalence in postmenopausal women, indicating the loss of estrogen protection on metabolic and cardiovascular health. Moreover
-
Protocol of a Prospective Observational Study on Lifestyle and Quality of Life in Adults with Type 1 Diabetes in Japan Diabetes Ther. (IF 3.8) Pub Date : 2024-02-15 Junko Sato, Kenichi Nakajima, Tomoya Mita, Mami Koshibu, Ayako Sato, Hiromasa Goto, Fuki Ikeda, Yuya Nishida, Katsumi Aso, Hirotaka Watada
Introduction Recent studies have shown that the quality of life (QOL) of people living with type 1 diabetes (T1D) is poor and must be improved. However, the living situation and QOL of adults living with T1D in Japan have not been fully clarified. This study will examine their lifestyle, QOL, and clinical situation, as well as the relationships between them. Methods This is a prospective, 5-year follow-up
-
Real-World Study on Effectiveness of Insulin Glargine U300 After Oral Antidiabetic Drug Failure in Patients with Type 2 Diabetes in the Gulf Region Diabetes Ther. (IF 3.8) Pub Date : 2024-02-15 Niaz E. Khan, AbdulRahman A. M. Al Shaikh, Ahmed A. K. Hassoun, Amr M. Hassan, Mona M. Salah, Nabeela A. Al Abdella, Saher S. M. Safarini, Waleed A. Al Dahi, Yasser A. Akil
-
Identifying Ontarians with Type 2 Diabetes Mellitus in Administrative Data: A Comparison of Two Case Definitions Diabetes Ther. (IF 3.8) Pub Date : 2024-02-10 Robyn L. Houlden, Nilasha Thayalan, Scott Shi, Atif Kukaswadia, Godfrey Mau, Aiden Liu
-
Risk of Dementia in Patients with Diabetes Using Sodium-Glucose Transporter 2 Inhibitors (SGLT2i): A Systematic Review, Meta-Analysis, and Meta-Regression Diabetes Ther. (IF 3.8) Pub Date : 2024-02-10 Pricilla Yani Gunawan, Paskalis Andrew Gunawan, Timotius Ivan Hariyanto
-
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis Diabetes Ther. (IF 3.8) Pub Date : 2024-02-04 Yukiko Onishi, Tomonori Oura, Masakazu Takeuchi
-
Treat Obesity to Treat Type 2 Diabetes Mellitus Diabetes Ther. (IF 3.8) Pub Date : 2024-02-04
Abstract Obesity, a multifactorial, relapsing chronic disease, serves as a gateway to a spectrum of metabolic, cardiovascular, mechanical and mental health problems. Over the last few decades, the global prevalence of obesity has surged nearly threefold, mirroring the escalating rates of type 2 diabetes mellitus (T2DM). This parallel trajectory strongly suggests a cause-and-effect relationship between
-
A Narrative Review of Diabetic Macroangiopathy: From Molecular Mechanism to Therapeutic Approaches Diabetes Ther. (IF 3.8) Pub Date : 2024-02-02 Jiacheng Yin, Xiaoxu Fu, Yue Luo, Yuling Leng, Lianjun Ao, Chunguang Xie
-
Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy Diabetes Ther. (IF 3.8) Pub Date : 2024-01-30 Poorva M. Nemlekar, Katia L. Hannah, Courtney R. Green, Gregory J. Norman
-
Therapeutic Inertia in the Management of Type 2 Diabetes: A Narrative Review Diabetes Ther. (IF 3.8) Pub Date : 2024-01-25 Paloma Rodriguez, Vicente T. San Martin, Kevin M. Pantalone
-
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study Diabetes Ther. (IF 3.8) Pub Date : 2024-01-19 Anastas Kick, Khadija M’Rabet-Bensalah, Flavio Acquistapace, Hanan Amadid, Robert A. Ambühl, Uffe Christian Braae, Flurin Item, Bernd Schultes, Thomas Züger, Gottfried Rudofsky
-
Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as Metformin Add-on in a Korean Population with Type 2 Diabetes Diabetes Ther. (IF 3.8) Pub Date : 2024-01-18 Byung-Wan Lee, Young Min Cho, Sin Gon Kim, Seung-Hyun Ko, Soo Lim, Amine Dahaoui, Jin Sook Jeong, Hyo Jin Lim, Jae Myung Yu
-
Emotional, Psychological, and Social Well-being Experience of Long-Term Living with Type 1 Diabetes Mellitus: A Patient–Psychiatrist–Endocrinologist Perspective Diabetes Ther. (IF 3.8) Pub Date : 2024-01-17 Mohammed Najeeb Ashraf, Alice Y. Y. Cheng, David J. Robinson
Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease that impacts blood glucose levels and can also lead to an increased prevalence of psychiatric conditions. Living with T1DM has been associated with a significant impact on a person’s social, mental, and psychological quality of life (QoL). Stressors related to T1DM include the demands of managing the condition, acceptance of the diagnosis
-
Impact of Living with Stigma in Persons with Type 1 Diabetes: A Patient–Physician Perspective Diabetes Ther. (IF 3.8) Pub Date : 2024-01-16 Mohammed Najeeb Ashraf, Alice Y. Y. Cheng
Type 1 diabetes mellitus (T1D) is an autoimmune disorder characterized by a complete deficiency in insulin due to the destruction of pancreatic beta cells. Globally, T1D accounts for nearly 5–10% of the total diabetes cases. Living with this life-long condition has a significant emotional, psychological, physical, mental, and social impact. Despite extensive research characterizing the underlying physiology
-
A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01) Diabetes Ther. (IF 3.8) Pub Date : 2024-01-13 Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
-
A Podcast on the Use of CGM in Optimizing Type 2 Diabetes Management with Non-intensive Insulin Treatment in the Primary Care Setting Diabetes Ther. (IF 3.8) Pub Date : 2024-01-13 Samuel Seidu
Introduction Type 2 diabetes is a widespread health concern with significant implications for patient well-being. Poor glycaemic control can lead to long-term complications, hypoglycaemia and glycaemic variability, highlighting the importance of setting treatment goals. This podcast, “The use of CGM in optimizing type 2 diabetes management with non-intensive insulin treatment in the primary care setting”
-
A Systematic Literature Review of Psychological Interventions for Adults with Type 1 Diabetes Diabetes Ther. (IF 3.8) Pub Date : 2024-01-06 Onyinye Diribe, Karen Palmer, Adee Kennedy, Marissa Betts, Katarzyna Borkowska, Cecile Dessapt-Baradez, Mike Baxter
-
The Effect of Sodium–Glucose Cotransporter Inhibitors on Renal Function as Adjunctive to Insulin in Adults with Type 1 Diabetes: An Updated Multilevel Meta-analysis of Randomized Controlled Trials Diabetes Ther. (IF 3.8) Pub Date : 2024-01-05 Paschalis Karakasis, Djordje S. Popovic, Dimitrios Patoulias, Theocharis Koufakis, Nikolaos Papanas, Nikolaos Fragakis, Manfredi Rizzo
-
Glycemic Control, Weight Management, Cardiovascular Safety, and Cost-Effectiveness of Semaglutide for Patients with Type 2 Diabetes Mellitus: A Rapid Review and Meta-analysis of Real-World Studies Diabetes Ther. (IF 3.8) Pub Date : 2024-01-04 Sihua Wang, Sheng Wang, Yan Wang, Jiajie Luan
-
Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Added to Dual or Triple Treatment in Patients with Type 2 Diabetes Mellitus Diabetes Ther. (IF 3.8) Pub Date : 2023-12-20
Abstract Introduction We evaluated the effectiveness and safety of sodium-glucose cotransporter 2 inhibitor (SGLT2i) add-on treatment in patients with type 2 diabetes mellitus (T2DM) in the real-world setting. Methods This single-center retrospective study used the clinical database of Seoul National University Hospital in South Korea. Patients who received metformin monotherapy or combination therapy
-
Evaluation of Age-Related Changes in Teneligliptin Pharmacokinetics in Japanese and European Descent Subjects Using a Physiologically Based Pharmacokinetic Model Diabetes Ther. (IF 3.8) Pub Date : 2023-12-20
Abstract Introduction Drugs often show differing pharmacokinetic (PK) profiles, such as higher plasma concentrations, in older people than in younger people owing to age-related decreases in physiological functions. However, it is difficult to evaluate the PK in older populations. Therefore, we simulated the plasma age-related changes in the PK of teneligliptin, a dipeptidyl peptidase-4 inhibitor,
-
Evaluating the Clinical Effectiveness and Safety of Semaglutide in Individuals with Uncontrolled Type 2 Diabetes. Real-World Evidence from Saudi Arabia: The Observational, Multicenter, 15-Month EVOLUTION Study Diabetes Ther. (IF 3.8) Pub Date : 2023-12-19 Abdulrahman Alsheikh, Ali Alshehri, Saad Alzahrani, Anwar A. Jammah, Fahad Alqahtani, Metib Alotaibi, Raed Aldahash, Amani M. Alhozali, Fahad Alsabaan, Mohammed Almehthel, Naser Aljuhani, Ali Aldabeis, Moneer Alamri, Waleed Maghawry, Naweed Alzaman, Alshaima Alshaikh, Omar M. Alnozha, Emad R. Issak, Saud Alsifri
-
Maternal Height Is an Independent Risk of Adverse Outcomes in Women with Gestational Diabetes Mellitus Diabetes Ther. (IF 3.8) Pub Date : 2023-12-17 Mengkai Du, Marie Parfaite Uwimana Muhuza, Yibo Tang, Yanmin Chen, Danqing Chen, Lixia Zhang, Zhaoxia Liang
-
Evaluation of System Accuracy, Precision, Hematocrit Influence, and User Performance of Two Blood Glucose Monitoring Systems Based on ISO 15197:2013/EN ISO 15197:2015 Diabetes Ther. (IF 3.8) Pub Date : 2023-12-15 Stefan Pleus, Nina Jendrike, Annette Baumstark, Jochen Mende, Stephanie Wehrstedt, Cornelia Haug, Guido Freckmann
-
Durability of Effectiveness Between Users of Once-Weekly Semaglutide and Dipeptidyl Peptidase 4 Inhibitors (DPP–4i) in US Adults with Type 2 Diabetes Diabetes Ther. (IF 3.8) Pub Date : 2023-12-07 Xi Tan, Yuanjie Liang, Cory Gamble, Aaron King
-
Safety, Metabolic and Psychological Outcomes of Medtronic MiniMed 780G™ in Children, Adolescents and Young Adults: A Systematic Review Diabetes Ther. (IF 3.8) Pub Date : 2023-12-01 Stefano Passanisi, Fortunato Lombardo, Chiara Mameli, Bruno Bombaci, Maddalena Macedoni, Gianvincenzo Zuccotti, Klemen Dovc, Tadej Battelino, Giuseppina Salzano, Maurizio Delvecchio
-
Impact of Weight Change on Glycemic Control and Metabolic Parameters in T2D: A Retrospective US Study Based on Real-World Data Diabetes Ther. (IF 3.8) Pub Date : 2023-12-01 Shraddha Shinde, Vivian Thuyanh Thieu, Anita Y. M. Kwan, Katherine Houghton, Juliana Meyers, David Schapiro
-
An Economic Evaluation of the Relationship Between Glycemic Control and Total Healthcare Costs for Adults with Type 2 Diabetes: Retrospective Cohort Study Diabetes Ther. (IF 3.8) Pub Date : 2023-12-01 Kristina S. Boye, Jay P. Bae, Vivian T. Thieu, Maureen J. Lage
-
Disease and Economic Burden of Poor Metabolic and Weight Control in Type 2 Diabetes in Spain: A Systematic Literature Review Diabetes Ther. (IF 3.8) Pub Date : 2023-11-22 Antonio Pérez, Jennifer Redondo-Antón, Irene Romera, Luís Lizán, Miriam Rubio-de Santos, Silvia Díaz-Cerezo, Domingo Orozco-Beltrán
-
Physician Perceptions of Dose Escalation for Type 2 Diabetes Medications in the United States Diabetes Ther. (IF 3.8) Pub Date : 2023-11-18 Kristina S. Boye, Jessica B. Jordan, Raleigh Malik, Louis S. Matza
-
Telehealth Use and Healthcare Utilization Among Individuals with Type 2 Diabetes During the COVID-19 Pandemic: Evidence From Louisiana Medicaid Claims Diabetes Ther. (IF 3.8) Pub Date : 2023-11-17 Yixue Shao, Lizheng Shi, Elizabeth Nauman, Eboni Price-Haywood, Charles Stoecker
Introduction The impact of telehealth use on healthcare utilization is limited, especially among Medicaid beneficiaries with type 2 diabetes. Considering the rapid adoption of telehealth during the COVID-19 pandemic, this study examined associations between telehealth use and healthcare utilization among Medicaid beneficiaries with type 2 diabetes. Methods Using Louisiana Medicaid claims data from
-
The International Working Group on the Diabetic Foot: Stories and Numbers Behind Three Decades of Evidence-Based Guidelines for the Management of Diabetes-Related Foot Disease Diabetes Ther. (IF 3.8) Pub Date : 2023-11-16 Jaap J. van Netten, Jan Apelqvist, Sicco A. Bus, Robert Fitridge, Fran Game, Matilde Monteiro-Soares, Eric Senneville, Nicolaas C. Schaper
-
Does a Ketogenic Diet Have a Place Within Diabetes Clinical Practice? Review of Current Evidence and Controversies Diabetes Ther. (IF 3.8) Pub Date : 2023-11-15 Chloe H. Firman, Duane D. Mellor, David Unwin, Adrian Brown
Carbohydrate restriction has gained increasing popularity as an adjunctive nutritional therapy for diabetes management. However, controversy remains regarding the long-term suitability, safety, efficacy and potential superiority of a very low carbohydrate, ketogenic diet compared to current recommended nutritional approaches for diabetes management. Recommendations with respect to a ketogenic diet
-
Clusters of Body Fat and Nutritional Parameters are Strongly Associated with Diabetic Kidney Disease in Adults with Type 2 Diabetes Diabetes Ther. (IF 3.8) Pub Date : 2023-11-14 Aiqin He, Caifeng Shi, Xiaomei Wu, Yuting Sheng, Xueting Zhu, Junwei Yang, Yang Zhou
-
A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin Diabetes Ther. (IF 3.8) Pub Date : 2023-11-14 Aditi Jain, Abhay Vispute, Amol Dange, Arindam Naskar, Asish Mondal, B. Vivekanand, Balram Sharma, Deepak Varade, Dhaiwat Shukla, Girish Bhatia, Harshal Chaudhari, K. Ram Babu, Onkar Gavali, Sanket Sorate, Shaishav Bhanushali, Vaibhav Kothari, Vipul Khandelwal, Akhilesh Sharma, Roshan Pawar, Mayur Mayabhate, Vinayaka Shahavi, Aashishsingh Rajput, Mukesh Jaiswal
-
Cost-Effectiveness of Pharmacist Care in Diabetes Management: A Systematic Review Diabetes Ther. (IF 3.8) Pub Date : 2023-11-14 Jiejin Zhu, Ying Zhou, Gang Wang
-
Potential New Therapeutic Implications of Semaglutide: New Colours of the Rainbow? Diabetes Ther. (IF 3.8) Pub Date : 2023-11-11 Evanthia Gouveri, Djordje S. Popovic, Nikolaos Papanas
Semaglutide is a potent glucagon-like peptide 1 receptor agonist for the management of type 2 diabetes mellitus. In addition to this, it has emerging potential clinical implications. First, there is accumulating preliminary data on its potential role in type 1 diabetes mellitus. In this setting, we need to know which patient subgroups may benefit more. Furthermore, its role in non-alcoholic fatty liver
-
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, and Dose-Increasing Study on the Safety, Tolerability and PK/PD of Multiple Doses of HSK7653 by Oral Administration in Patients with Type 2 Diabetes Mellitus in China Diabetes Ther. (IF 3.8) Pub Date : 2023-11-06 Nan Bai, Jin Wang, Wenxin Liang, Leili Gao, Wei Cui, Qinghe Wu, Fangqiong Li, Linong Ji, Yun Cai
-
Optimizing Collaborative Care of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes: An Example Practice Model at a Health Care Practice in Kentucky, United States Diabetes Ther. (IF 3.8) Pub Date : 2023-11-02 Benjamin Gatlin, Jamie Miller, Sergio Chang
-
Midnight Cortisol is Associated with Changes in Systolic Blood Pressure and Diabetic Neuropathy in Subjects with Type 1 Diabetes Undergoing Simultaneous Kidney-Pancreas Transplantation Diabetes Ther. (IF 3.8) Pub Date : 2023-11-02 Laura Boswell, Antonio J. Amor, Enrique Montagud-Marrahi, Gregori Casals, Daniela Díaz-Catalan, Elisenda Banon-Maneus, María José Ramírez-Bajo, Natalia Hierro, Fritz Diekmann, Mireia Musquera, Tonet Serés-Noriega, Enric Esmatjes, Joana Ferrer-Fàbrega, Pedro Ventura-Aguiar, Felicia A. Hanzu
-
Optimizing Diabetes Management Using a Low-Calorie Diet in Saudi Arabia: A Cost-Benefit Analysis Diabetes Ther. (IF 3.8) Pub Date : 2023-10-27 Saud Al Sifri, Raed Aldahash, Daniel-Antonio de Luis Roman, Ahmed Amin, María Camprubi-Robles, Kirk W. Kerr, Alina Juusti-Hawkes, Ariel Beresniak
-
Albuminuria and Serum Tumor Necrosis Factor Receptor Levels in Patients with Type 2 Diabetes on SGLT2 Inhibitors: A Prospective Study Diabetes Ther. (IF 3.8) Pub Date : 2023-10-26 Toshiki Otoda, Akiko Sekine, Ryoko Uemoto, Seijiro Tsuji, Tomoyo Hara, Motoyuki Tamaki, Tomoyuki Yuasa, Toshiaki Tamaki, Munehide Matsuhisa, Ken-ichi Aihara
-
Study Protocol for the Pleiotropic Effects of Sodium–Glucose Cotransporter 2 Inhibitor on Organ-Specific Sympathetic Nerve Activity and Insulin Sensitivity in Participants with Type 2 Diabetes Diabetes Ther. (IF 3.8) Pub Date : 2023-10-26 Yumie Takeshita, Chiaki Nomura, Hisayoshi Murai, Yusuke Mukai, Tadayuki Hirai, Takuto Hamaoka, Shota Tokuno, Takeo Tanaka, Hisanori Goto, Yujiro Nakano, Soichiro Usui, Kenichi Nakajima, Masayuki Takamura, Toshinari Takamura
-
Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production Diabetes Ther. (IF 3.8) Pub Date : 2023-10-26 Umberto Capece, Chiara Pavanello, Francesca Cinti, Lucia Leccisotti, Teresa Mezza, Gea Ciccarelli, Simona Moffa, Gianfranco Di Giuseppe, Laura Soldovieri, Michela Brunetti, Alessandro Giordano, Andrea Giaccari, Laura Calabresi, Alice Ossoli